Show simple item record

FieldValueLanguage
dc.contributor.authorTendal, Brittaen
dc.contributor.authorVogel, Joshua P.en
dc.contributor.authorMcDonald, Steveen
dc.contributor.authorNorris, Sarahen
dc.contributor.authorCumpston, Mirandaen
dc.contributor.authorWhite, Heathen
dc.contributor.authorLeder, Karinen
dc.contributor.authorNavarro, David Fraileen
dc.contributor.authorCheyne, Saskiaen
dc.contributor.authorChakraborty, Samanthaen
dc.contributor.authorMurano, Melissaen
dc.contributor.authorMillard, Tanyaen
dc.contributor.authorCallesen, Henriette E.en
dc.contributor.authorIslam, Rakibul M.en
dc.contributor.authorElliott, Julianen
dc.contributor.authorTurner, Tarien
dc.date.accessioned2020-12-21
dc.date.available2020-12-21
dc.date.issued2021en
dc.identifier.urihttps://hdl.handle.net/2123/24206
dc.description.abstractBACKGROUND: The Australian National COVID-19 Clinical Evidence Taskforce is a consortium of 31 Australian health professional organisations developing living, evidence-based guidelines for care of people with COVID-19 which are updated weekly. This paper describes the methods used to develop and maintain the guidelines. METHODS: The guidelines use GRADE methods and are designed to meet Australian NHMRC standards. Each week, new evidence is reviewed, current recommendations are revised and new recommendations made. These are published in MAGIC and disseminated through traditional and social media. Relevant new questions to be addressed are continually sought from stakeholders and practitioners. For prioritised questions, the evidence is actively monitored and updated. Evidence surveillance combines horizon scans and targeted searches. An Evidence Team appraises and synthesises evidence and prepares evidence-to-decision frameworks to inform development of recommendations. A Guidelines Leadership Group oversees the development of recommendations by multidisciplinary Guidelines Panels and is advised by a Consumer Panel. RESULTS: and Discussion: The Taskforce formed in March 2020, and the first recommendations were published two weeks later. The guidelines have been revised and republished on a weekly basis for 24 weeks, and as of October 2020 contain over 90 treatment recommendations, suggesting that living methods are feasible in this context. CONCLUSIONS: The Australian Guidelines for Care of People with COVID-19 provide an example of the feasibility of living guidelines, and an opportunity to test and improve living evidence methods.en
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleWeekly updates of national living evidence-based guidelines: Methods for the Australian Living Guidelines for Care of People with COVID-19en
dc.typeArticleen
dc.identifier.doi10.1016/j.jclinepi.2020.11.005
dc.relation.otherDSF Charitable Foundation, DSFCF Australian Association of Gerontology, AAG Australian College of Critical Care Nurses, ACCCN Australian and New Zealand Society for Geriatric Medicine, ANZSGM Royal Australasian College of Surgeons, RACS Australasian Society for Infectious Diseases, ASID Department of Health and Human Services, State Government of Victoria, DHHS Equity Trustees Ian Potter Foundation, IPF Australian Association for Academic Primary Care, AAAPC Australasian Sleep Association, ASA Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, ASCEPT Australian and New Zealand College of Anaesthetists, ANZCA Australian Society of Anaesthetists, ASA Royal Australasian College of Physicians, RACP Department of Health, Australian Governmenten
usyd.facultyFaculty of Medicine and Health, NHMRC Clinical Trials Centreen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.